Orthotopic human lung carcinoma xenografts in BALB/c mice immunosuppressed with anti-CD4 monoclonal antibodies and chronic alcohol consumption

Cancer

Volumn 88, Issue 2, 2000, Pages 468-479

  Hunt, Jay D ^a   Robert, Everett G ^a   Zieske, Arthur W ^a   Bautista, Abraham P ^a   Bukara, Mirjana ^a   Lei, Dinghua ^a   Shellito, Judd E ^a   Nelson, Steve ^a   Kolls, Jay K ^a   Skrepnik, Nebojsa ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acquired immunodeficiency syndrome; Alcohol consumption; Alcoholism; CD4; Human immunodeficiency virus; Immunodeficiency; Nonsmall cell lung carcinoma; T lymphocyte

Indexed keywords

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ARTICLE; CANCER GROWTH; CANCER IMMUNOLOGY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LUNG CARCINOMA; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0034650293     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(20000115)88:2<468::aid-cncr30>3.0.co;2-%23     Document Type: Article

References (52)

1. Krown SE. AIDS-associated malignancies. In: Pinedo HM, Longo DL, Chabner BA. Cancer chemotherapy and biological response modifiers, Annual 16. New York: Elsevier Science, 1996:441-61.
2. Safai B, Diaz B, Schwartz J. Malignant neoplasms associated with human immunodeficiency virus infection. CA Cancer J Clin 1992;42:74-95.
3. Biggar RJ, Burnett W, Miki J, Nasca P. Cancer among New York men at risk of acquired immunodeficiency syndrome. Int J Cancer 1989;43:979-85.
4. White DA, Matthay RA. Noninfectious pulmonary complications of infection with the human immunodeficiency virus. Am Rev Respir Dis 1989;140:1763-87.
5. Peterschmitt AM, Moro DG, Perron HJ, Brambilla EB. Bronchoalveolar carcinoma, lymphoid interstitial pneumonia, and retroviruses [letter]. Clin Infect Dis 1994;19:1178-9.
6. Aaron SD, Warner E, Edelson JD. Bronchogenic carcinoma in patients seropositive for human immunodeficiency virus. Chest 1994;106:640-2.
7. Irwin LE, Begandy MK, Moore TM. Adenosquamous carcinoma of the lung and the acquired immunodeficiency syndrome [letter]. Ann Intern Med 1984;100:158.
8. Nguyen VQ, Ossorio MA, Roy TM. Bronchogenic carcinoma and the acquired immunodeficiency syndrome. J Ky Med Assoc 1991;89:322-4.
9. Tenholder MF, Jackson HD. Bronchogenic carcinoma in patients seropositive for human immunodeficiency virus. Chest 1993;104:1049-53.
10. Gruden JF, Webb WR, Yao DC, Klein JS, Sandhu JS. Bronchogenic carcinoma in 13 patients infected with the human immunodeficiency virus (HIV): clinical and radiographic findings. J Thorac Imaging 1995;10:99-105.
11. Fraire AE, Awe RJ. Lung cancer in association with human immunodeficiency virus infection. Cancer 1992;70:432-6.
12. Sridhar KS, Flores MR, Raub WA Jr., Saldana M. Lung cancer in patients with human immunodeficiency virus infection compared with historic control subjects. Chest 1992;102: 1704-8.
13. Karp J, Profeta G, Marantz PR, Karpel JP. Lung cancer in patients with immunodeficiency syndrome. Chest 1993;103: 410-3.
14. Chan TK, Aranda CP, Rom WN. Bronchogenic carcinoma in young patients at risk for acquired immunodeficiency syndrome. Chest 1993;103:862-4.
15. Monfardini S, Vaccher E, Pizzocaro G, Stellini R, Sinicco A, Sabbatani S, et al. Unusual malignant tumours in 49 patients with HIV infection. AIDS 1989;3:449-52.
16. Braun MA, Killam DA, Remick SC, Ruckdeschel JC. Lung cancer in patients seropositive for human immunodeficiency virus. Radiology 1990;175:341-3.
17. Fishman JE, Schwartz DS, Sais GJ, Flores MR, Sridhar KS. Bronchogenic carcinoma in HIV-positive patients: findings on chest radiographs and CT scans. AJR Am J Roentgenol 1995;164:57-61.
18. Beckstead J. The acquired immunodeficiency syndrome and neoplasia. Prog AIDS Pathol 1989;1:201-12.
19. Buonaguro F, Beth-Giraldo E, Giraldo G. Prospected etiopathogenic mechanisms of AIDS-associated tumors. Antibiot Chemother 1991;43:96-114.
20. Wang JY, Liang B, Watson RR. Alcohol consumption alters cytokine release during murine AIDS. Alcohol 1997;14:155-9.
21. Fitzpatrick EA, Rhoads CA, Espandiari P, Kaplan AM, Cohen DA. Ethanol as a possible cofactor in the development of murine AIDS. Alcohol Clin Exp Res 1995;19:915-22.
22. Chiappelli F, Kung M, Lee P, Pham L, Manfrini E, Villanueva P. Alcohol modulation of human normal T-cell activation, maturation, and migration. Alcohol Clin Exp Res 1995;19: 539-44.
23. Kolls JK, Lei D, Odom G, Nelson S, Summer WR, Gerber MA, et al. Use of transient CD4 lymphocyte depletion to prolong transgene expression of E1-deleted adenoviral vectors. Hum Gene Ther 1996;7:489-97.
24. Restifo NP, Wunderlich JR. Biology of cellular immune responses. In: DeVita VT Jr., Hellman S, Rosenberg SA. Biologic therapy of cancer. 2nd edition. Philadelphia: J. B. Lippincott, 1995:3-37.
25. Skrepnik N, Araya JC, Qian Z, Xu H, Hamide J, Mera R, et al. Effects of anti-erbB-2 (HER-2/neu) recombinant oncotoxin AR209 on human non-small cell lung carcinoma grown orthotopically in athymic nude mice. Clin Cancer Res 1996;2: 1851-7.
26. Hamide JP, Qian Z, Xu H, Diethelm L, Skrepnik N, Castaneda-Zuniga WR, et al. Percutaneous implantation of non-small cell lung carcinoma: technique and observations. Acad Radiol 1997;4:629-33.
27. Siegfried JM. Culture of primary lung tumors using medium conditioned by a lung carcinoma cell line. J Cell Biochem 1989;41:91-5.
28. Bautista AP. Chronic alcohol intoxication induces hepatic injury through enhanced macrophage inflammatory protein-2 production and intercellular adhesion molecule-1 expression in the liver. Hepatology 1997;25:335-42.
29. Fridman R, Kibbey MC, Royce LS, Zain M, Sweeny TM, Jicha DJ, et al. Enhanced tumor growth of both primary and established human and murine tumor cells in athymic mice after coinjection with matrigel. J Natl Cancer Inst 1991;83: 769-74.
30. Beck JM, Warnock ML, Curtis JL, Sniezek MJ, Arraj-Peffer SM, Kaltreider HB, et al. Inflammatory responses to Pneumocystis carinii in mice selectively depleted of helper T lymphocytes. Am J Respir Cell Mol Biol 1991;5: 186-97.
31. Kasprzyk PG, Sullivan TL, Hunt JD, Gubish CT, Scoppa CA, Oelkuct M, et al. Activity of Anti-erbB-2 recombinant toxin OLX-209 on lung cancer cell lines in the absence of erbB-2 gene amplification. Clin Cancer Res 1996;2:75-80.
32. Foley EJ. Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin. Cancer Res 1953;13:835-7.
33. Prehn RT, Main JM. Immunity to methycholanthrene-induced sarcomas. J Natl Cancer Inst 1957;18:769-78.
34. Burnet FM. Immunological surveillance. Oxford: Pergamon, 1970.
35. Kieff E. Epstein-Barr virus: increasing evidence of a link to carcinoma. N Engl J Med 1995;333:724-6.
36. Montone KT, Litzky LA, Wurster A, Kaiser L, Bavaria J, Kotloff R, et al. Analysis of Epstein-Barr virus-associated pos-transplantation lymphoproliferative disorder after lung transplantation. Surgery 1996;119:544-51.
37. Hardie IR, Strong RW, Hartley LC, Woodruff PW, Clunie GJ. Skin cancer in Caucasian renal allograft recipients living in a subtropical climate. Surgery 1980;87:177-83.
38. Greenberg PD. Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. Adv Immunol 1991;49:281-355.
39. Shen X, König R. Regulation of T cell immunity and tolerance in vivo by CD4. Int Immunol 1998;10:247-57.
40. Qin Z, Richter G, Schüler T, Ibe S, Cao X, Blankenstein T. B cells inhibit induction of T cell-dependent tumor immunity. Nat Med 1998;4:627-30.
41. Schüler T, Qin Z, Ibe S, Noben-Trauth N, Blankenstein T. T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice. J Exp Med 1999;189:803-10.
42. Kern DE, Klarnet JP, Jensen MCV, Greenberg PD. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL. J Immunol 1986;136:4303-10.
43. Greenberg PD, Cheever MA, Fefer A. Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2-lymphocytes. J Exp Med 1981;154:952-63.
44. Greenberg PD, Kern DE, Cheever MA. Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2-T cells. Tumor eradication does not require participation of cytotoxic T cells. J Exp Med 1985;161:1122-34.
45. Fujiwara H, Fukuzawa M, Yoshioka T, Nakajima H, Hamaoka T. The role of tumor-specific Lyt-1+2-T cells in eradicating tumor cells in vivo. I. Lyt-1+2 -T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity. J Immunol 1984;133:1671-6.
46. Tempero RM, VanLith ML, Morikane K, Rowse GJ, Gendler SJ, Hollingsworth MA. CD4+ lymphocytes provide MUC1-specific tumor immunity in vivo that is undetectable in vitro and is absent in MUC1 transgenic mice. J Immunol 1998; 161:5500-6.
47. Chang MP, Norman DC. Mechanism of ethanol-mediated immunosuppression in mice: ethanol suppresses T-cell proliferation with affecting IL2 production and IL2 receptor expression. Int J Immunopharmacol 1992;14:707-19.
48. Blank SE, Pfister LJ, Gallucci RM, Meadows GG. Ethanol-induced changes in peripheral blood and splenic natural killer cells. Alcohol Clin Exp Res 1993;17:561-5.
49. Gallucci RM, Pfister LJ, Meadows GG. Effects of ethanol consumption on enriched natural killer cells from C57BL/6 mice. Alcohol Clin Exp Res 1994;18:625-31.
50. Gallucci RM, Meadows GG. Ethanol consumption suppresses IL-2-induced proliferation on NK cells. Toxicol Appl Pharmacol. 1996;138:90-7.
51. McManus TJ, Weatherburn P. Alcohol, AIDS and immunity. Br Med Bull 1994;50:115-23.
52. Wang Y, Watson RR. Is alcohol a cofactor in the development of acquired immunodeficiency syndrome? Alcohol 1995;12:105-9.